It’s a powerful film that has received praise during its festival runs and limited theatrical release in the past couple of ...

Six months reading only authors who died by suicide reshaped my mind, habits, and relationship with books in unsettling ways., Books, Times Now ...

Ventripoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF) is building a subscription business around technology that converts standard 2D ultrasound images into detailed 3D heart models with MRI-level ...

Python.Org is the official source for documentation and beginner guides. Codecademy and Coursera offer interactive courses for learning Python basics. Think Python provides a free e-book for a ...

Theorem raises $6 million to use AI-powered formal verification to mathematically prove AI-generated code is safe before it's deployed in critical systems.

Integrated Biosciences has a new Chief Scientific Officer (CSO), naming Daniel J. Anderson, PhD, to the post. Anderson joins ...

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...